ImmunityBio, Inc. today announced that the Michael E. DeBakey Department of Veterans Affairs (VA) Medical Center recently became the first VA hospital in the Houston, Texas, region and one of the first in the U.S. to provide bladder cancer treatment with ANKTIVA®.
A 2024 study found military exposure to carcinogenic agents was associated with a higher risk for bladder cancer among veterans, making this treatment especially vital for those at the VA.
Read More
